Dexmedetomidine Infusion Dosing for Sedation

ICU Sedation (mechanically ventilated adults)

• Loading dose: 1 mcg/kg IV over 10 minutes (per FDA label). Many ICUs now skip the loading dose and start maintenance directly, since bolus loading increases the risk of bradycardia and hypotension.
• Maintenance infusion: 0.2-0.7 mcg/kg/hour, titrated to the desired sedation level (e.g., target RASS score). This is the FDA-approved maintenance range - Katzung's Pharmacology, p. (Clinical Uses & Dosage, block5).
  • Many institutions start lower, at 0.2-0.4 mcg/kg/hr, and titrate up by 0.1-0.2 mcg/kg/hr increments every 30 minutes.
  • Off-label/higher-dose use up to 1.5 mcg/kg/hr is described when standard doses are inadequate; doses up to 2.5 mcg/kg/hr have been reported in literature, though evidence suggests doses above ~1.5 mcg/kg/hr rarely add benefit and increase side-effect risk (bradycardia, hypotension).
• Duration: manufacturer labeling states infusions are intended for up to 24 hours, though longer durations (reported means around 65 hours in ICU studies) have been used safely in practice with daily reassessment.

General Anesthesia Adjunct / Procedural Sedation

• Loading dose: 0.5-1.0 mcg/kg IV over 10-15 minutes (0.5 mcg/kg over 10 min may be used in patients over 65 or for less invasive procedures, given greater hemodynamic sensitivity).
• Maintenance: 0.2-0.7 mcg/kg/hour infusion, decreasing the dose requirement for concurrent inhaled/IV anesthetics - Katzung's Basic and Clinical Pharmacology, 16th ed, p. (Clinical Uses & Dosage).

Adjustments and Cautions

• Elderly (>65 years) or hepatic impairment: consider dose reduction; renal impairment does not require dose adjustment per label, though caution is still advised.
• Cardiovascular effects: dexmedetomidine infusion causes dose-dependent decreases in heart rate, systemic vascular resistance, and blood pressure; a rapid bolus can transiently raise blood pressure while dropping heart rate further, so bolus loading is often avoided in hemodynamically labile patients - Miller's Anesthesia, 10th ed (Effects on the Cardiovascular System, block7) and Katzung's Pharmacology.
• Pharmacokinetics: elimination half-life is 2-3 hours; context-sensitive half-time ranges from ~4 minutes after a 10-minute infusion to as long as 250 minutes after prolonged (8+ hour) infusions, which matters for recovery time planning - Miller's Anesthesia, 10th ed, p. 2324-2329.
• Must be administered via a controlled infusion pump; not given as a rapid IV push for sedation.

Recent evidence note

Fentanyl Infusion Dose for Sedation

ICU Sedation/Analgesia (mechanically ventilated adults)

• Loading dose: 1-2 mcg/kg IV bolus (some protocols give this as a rapid infusion of ~1 mcg/kg/min over the first 10 minutes rather than a single push). Most ICU patients can be managed without a bolus; if one is needed, 0.5 mcg/kg is usually sufficient, as larger boluses cause more pronounced drops in heart rate and blood pressure.
• Maintenance infusion: typically 0.7-10 mcg/kg/hour, though most patients do well on the lower end, around 0.5-2 mcg/kg/hour (roughly 25-100 mcg/hour for an average-sized adult). Titrate to a validated pain/sedation scale.
• Intermittent alternative: 0.35-0.5 mcg/kg every 30-60 minutes if not using a continuous drip.
• Practical ICU teaching favors avoiding continuous infusions when possible in favor of intermittent bolus dosing, because fentanyl accumulates in peripheral fat/muscle with prolonged infusions, prolonging its context-sensitive half-time and delaying awakening - Miller's Anesthesia, 10e (Volume of Distribution at the Time of Peak Effect, block8, lines 3738-3817).

Intraoperative/Anesthesia Use

• Infusion during general anesthesia: 1-2 mcg/kg/hour produces stable hemodynamics with fewer swings in heart rate and blood pressure, which is especially useful in neonates/infants who tolerate hemodynamic instability poorly - Miller's Anesthesia, 10e (Induction and Maintenance of Anesthesia, block29, lines 4482-4488).
• Major surgery (bolus + infusion approach): initial dose 2-20 mcg/kg, followed by 1-2 mcg/kg/hour maintenance; infusion is typically stopped 30-60 minutes before the end of surgery to allow timely emergence; total dose is often capped at 10-15 mcg/kg for fast-track extubation protocols.

Pediatric Considerations

• Weight-based dosing in mcg/kg/hr is used for children under ~40 kg; the infusion may be increased by about 1 mcg/kg/hr every 30-60 minutes as needed, titrated to effect.
• For patients ≥40 kg, some protocols start infusions at a fixed adult-equivalent rate (~100 mcg/hr) and titrate up by 50-100 mcg/hr increments every 30-60 minutes.

Key Pharmacologic Notes

• Elimination half-life: 30-60 minutes acutely, but extends to 9-16 hours with prolonged dosing due to drug accumulation in peripheral tissue - contributes to delayed recovery after long infusions.
• Onset: roughly 1-2 minutes after IV bolus; peak effect at 6-15 minutes.
• Fentanyl has minimal histamine release, giving it a hemodynamic advantage (less hypotension) compared to morphine, making it a preferred opioid in hemodynamically unstable ICU patients.

Comparison caveat

Heparin: IV vs Subcutaneous Administration

Give IV when:

• Acute venous thromboembolism (DVT/PE) treatment: Loading bolus of 80 units/kg (max ~5,000-10,000 units) followed by a continuous infusion starting at 18 units/kg/hour (general range ~10-25 units/kg/hr), titrated to aPTT or anti-Xa levels - Rosen's Emergency Medicine and UW Medicine Anticoagulation protocols.
• Acute coronary syndromes / PCI: requires immediate, precisely controlled anticoagulant effect during the procedure.
• Bridging in patients with mechanical heart valves, atrial fibrillation with high stroke risk, or arterial thrombosis - continuous IV infusion is preferred over subcutaneous dosing for arterial indications.
• Any situation where continuous, steady-state anticoagulation with close lab monitoring (aPTT/anti-Xa every 6 hours after dose changes) is required. Continuous IV infusion is actually preferred over intermittent IV bolus dosing because intermittent boluses cause more bleeding complications - Medscape/Katzung's Pharmacology.

Give Subcutaneous when:

• VTE prophylaxis in hospitalized, surgical, or immobile medical patients: fixed low-dose regimens such as 5,000 units SC every 8-12 hours (unmonitored, non-weight-based) - Katzung's Pharmacology and Hinman's Atlas of Urologic Surgery.
• Adjusted-dose (full-intensity) subcutaneous heparin as an alternative to IV infusion for treatment of acute thrombosis, e.g., when IV access is problematic or for outpatient/bridging therapy: loading dose ~240-333 units/kg SC, then weight-based dosing (e.g., 250 units/kg SC every 12 hours) with aPTT monitoring 6 hours after each dose adjustment - UW Medicine Anticoagulation Services.
• Pregnancy: UFH does not cross the placenta, and subcutaneous dosing is generally preferred for prophylaxis or treatment during pregnancy over IV, given the need for extended outpatient use.
• Transitioning off IV heparin to a maintenance anticoagulation strategy (e.g., before switching to warfarin or discharge), or transitioning from IV infusion back to adjusted-dose SC, calculated from the total daily IV requirement split into two doses.
• Perioperative bridging in patients on chronic anticoagulation who need reduced-intensity coverage around procedures (e.g., 5,000 units SC every 8-12 hours for moderate-risk surgical patients).

Key practical distinctions